Phibro Animal Health (NASDAQ:PAHC) was downgraded by investment analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report released on Tuesday.
PAHC has been the subject of several other reports. Piper Jaffray Companies set a $41.00 target price on Phibro Animal Health and gave the stock a “buy” rating in a research note on Friday, October 6th. Zacks Investment Research cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st. Credit Suisse Group boosted their target price on Phibro Animal Health from $36.00 to $37.00 and gave the stock an “outperform” rating in a research note on Thursday, August 31st. ValuEngine cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Finally, Bank of America reissued an “underperform” rating and set a $33.00 target price on shares of Phibro Animal Health in a research note on Wednesday, August 23rd. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $38.25.
Shares of Phibro Animal Health (NASDAQ PAHC) traded up $0.10 during midday trading on Tuesday, hitting $33.35. The stock had a trading volume of 432,321 shares, compared to its average volume of 102,787. Phibro Animal Health has a twelve month low of $26.10 and a twelve month high of $40.25. The company has a debt-to-equity ratio of 1.91, a current ratio of 3.26 and a quick ratio of 1.85. The firm has a market capitalization of $1,340.10, a PE ratio of 21.80, a PEG ratio of 3.91 and a beta of 1.27.
Large investors have recently added to or reduced their stakes in the company. Municipal Employees Retirement System of Michigan boosted its position in shares of Phibro Animal Health by 3.6% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock worth $162,000 after acquiring an additional 150 shares in the last quarter. KBC Group NV acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth about $166,000. Victory Capital Management Inc. boosted its position in shares of Phibro Animal Health by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 5,380 shares of the company’s stock worth $199,000 after acquiring an additional 807 shares in the last quarter. Capital Fund Management S.A. acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth about $210,000. Finally, Susquehanna International Group LLP acquired a new position in shares of Phibro Animal Health during the 2nd quarter worth about $219,000. 48.42% of the stock is owned by institutional investors and hedge funds.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.